Kim J, Harper A, McCormack V et al (2025) Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med 31(4):1154–1162. https://doi.org/10.1038/s41591-025-03502-3

Article  PubMed  Google Scholar 

Xu Y, Gong M, Wang Y et al (2023) Global trends and forecasts of breast cancer incidence and deaths. Sci Data 10(1):334 Published 2023 May 27. https://doi.org/10.1038/s41597-023-02253-5

Article  PubMed  PubMed Central  Google Scholar 

Oda G, Nakagawa T, Mori H et al (2022) Factors predicting upstaging from clinical N0 to pN2a/N3a in breast cancer patients. World J Clin Oncol 13(9):748–757. https://doi.org/10.5306/wjco.v13.i9.748

Article  PubMed  PubMed Central  Google Scholar 

Giannakou A, Gooch J, Gergelis KR et al (2023) De-escalation of axillary surgery in patients outside Z0011 criteria. Surgery 174(2):416–418. https://doi.org/10.1016/j.surg.2023.03.024

Article  PubMed  Google Scholar 

Gradishar WJ, Moran MS, Abraham J et al (2024) Breast Cancer, version 3.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 22(5):331–357. https://doi.org/10.6004/jnccn.2024.0035

Article  PubMed  Google Scholar 

Weiss A, Cooley V, Al-Hilli Z et al (2021) Extrapolation of ACOSOG Z0011 trial results-A survey of breast cancer providers. Breast J 27(6):537–542. https://doi.org/10.1111/tbj.14226

Article  PubMed  Google Scholar 

Kumar N, Ehsan S, Banerjee S et al (2024) The unique risk factor profile of triple-negative breast cancer: a comprehensive meta-analysis. J Natl Cancer Inst 116(8):1210–1219. https://doi.org/10.1093/jnci/djae056

Article  PubMed  PubMed Central  Google Scholar 

Wang NN, Yang ZJ, Wang X et al (2018) A mathematical prediction model incorporating molecular subtype for risk of non-sentinel lymph node metastasis in Sentinel lymph node-positive breast cancer patients: a retrospective analysis and nomogram development. Breast Cancer 25(6):629–638. https://doi.org/10.1007/s12282-018-0863-7

Article  PubMed  Google Scholar 

Li Y, Zhang H, Merkher Y et al (2022) Recent advances in therapeutic strategies for triple-negative breast cancer. J Hematol Oncol 15(1):121. Published 2022 Aug 29. https://doi.org/10.1186/s13045-022-01341-0

Article  PubMed  PubMed Central  Google Scholar 

Maturo F, Rambaud SC (2022) On the use of propensity score matching in biomedicine and pulmonology. Arch Bronconeumol 58(9):637–639. https://doi.org/10.1016/j.arbres.2021.12.010

Article  PubMed  Google Scholar 

Baranova A, Krasnoselskyi M, Starikov V et al (2022) Triple-negative breast cancer: current treatment strategies and factors of negative prognosis. J Med Life 15(2):153–161. https://doi.org/10.25122/jml-2021-0108

Article  PubMed  PubMed Central  Google Scholar 

Sejben A, Nyári T, Zombori T et al (2020) Comparison of Nottingham prognostic Index, PREDICT and prognostils in triple negative breast cancer -a retrospective cohort study. Pathol Oncol Res 26(4):2443–2450. https://doi.org/10.1007/s12253-020-00846-8

Article  PubMed  Google Scholar 

Giuliano AE, Ballman KV, McCall L et al (2017) Effect of axillary dissection vs no axillary dissection on 10-Year overall survival among women with invasive breast cancer and Sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA 318(10):918–926. https://doi.org/10.1001/jama.2017.11470

Article  PubMed  PubMed Central  Google Scholar 

Soni A, Morgan J, Jacques R et al (2025) Trends in the rate of axillary clearance following the publication of the ACOSOG Z0011 trial: a systematic review. Eur J Surg Oncol. Published Online April 12. https://doi.org/10.1016/j.ejso.2025.110023

Matuschek C, Jazmati D, Bölke E et al (2022) Post-Neoadjuvant treatment strategies in breast cancer. Cancers (Basel) 14(5):1246 Published 2022 Feb 28. https://doi.org/10.3390/cancers14051246

Article  PubMed  Google Scholar 

Simons JM, Koppert LB, Luiten EJT et al (2020) De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study. Breast Cancer Res Treat 180(3):725–733. https://doi.org/10.1007/s10549-020-05589-3

Article  PubMed  PubMed Central  Google Scholar 

Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347(16):1233–1241. https://doi.org/10.1056/NEJMoa022152

Article  PubMed  Google Scholar 

Whelan TJ, Olivotto IA, Parulekar WR et al (2015) Regional nodal irradiation in Early-Stage breast cancer. N Engl J Med 373(4):307–316. https://doi.org/10.1056/NEJMoa1415340

Article  PubMed  PubMed Central  Google Scholar 

Poortmans P PM, Weltens C, Fortpied C et al (2020) Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial [published correction appears in lancet Oncol. 2021;22(1):e5. Doi: 10.1016/S1470-2045(20)30733-6]. Lancet Oncol 21(12):1602–1610. https://doi.org/10.1016/S1470-2045(20)30472-1

EBCTCG (Early Breast Cancer Trialists’ Collaborative Group), McGale P, Taylor C et al (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. 383(9935):2127–2135. https://doi.org/10.1016/S0140-6736(14)60488-8